Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19 research v0.36 | CD79A |
Ellen McDonagh gene: CD79A was added gene: CD79A was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,London North GLH,A- or hypo-gammaglobulinaemia v1.25,IUIS Classification February 2018 Mode of inheritance for gene: CD79A was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CD79A were set to 19302039; 11920841; 24481606; 10525050; 29335801; 24909997 Phenotypes for gene: CD79A were set to Agammaglobulinemia; Agammaglobulinemia 3, 613501; Severe bacterial infections, normal numbers of pro-B cells; Agammaglobulinemia with autosomal recessive inheritance (ARA); Predominantly Antibody Deficiencies; CD79A deficiency; Agammaglobulinemia 3 |